Page 3 - Rua Bioscience News Today

Rua Bioscience announced its official entry into the dynamic Australian medicinal cannabis market. Teaming up with Anspec, a leading pharmaceutical distribution company, Rua Bioscience product is now...

The NZ sharemarket fell more than 4 per cent in August.

The index had a choppy trading session on the day National announced its tax plan.

Rua Bioscience ( NZSE:RUA ) Full Year 2023 Results Key Financial Results Net loss: NZ$5.96m (loss narrowed by 31% from...

Results in line with expectations and achieves first international sales. Summary financials   FY23 $ FY22 $ Revenue (from customers) 357,675 24,226 Revenue (incl. fair value gains) 6,532,612 646,098 Profit/(Loss) before tax (5,958,506) (7,485,985) ...

Business Scoop provides news and views on Business and Markets from New Zealand

Shane Reti's verdict.

Meanwhile, the index had a muted response to the hold on the official cash rate.

The dope dozen: the most influential NZ players on the medicinal scene.

Meanwhile, Ebos continued to reel after losing its Chemist Warehouse Australian contract.